Abstract:OBJECTIVE:To investigate the expression of fascin and cytokeratin 14 (CK14) in human esophageal squamous cell carcinoma (ESCC) and the association of these two proteins with ESCC malignant progression and the possibility of application of these 2 proteins in the diagnosis of ESCC.METHODS:A tissue microarray composed of the representative regions of ESCC and corresponding normal epithelium was constructed. Immunohistochemistry was conducted to examine the expression of fascin and CD14 in 116 specimens of ESCC and the normal tissues near the cancerous tissues. The relation of these two proteins with the invasive depth, node involvement, differentiated grade, pTNM stages was analyzed. Disease-free survival analysis was carried out using Kaplan-Meier method. The correlation of the two proteins was analyzed using Spearman's correlation test. ESCC cells of the lines EC9706, TE12, COLO-680N, KYSE510, KYSE450, KYSE410, KYSE180, KYSE150, KYSE140, KYSE70, KYSE30, and YES2 were cultured and underwent SDS-PAGE and Western blotting to examine the expression of fascin and CD14. And the correlation of the two proteins with the characteristics of the cell lines was analyzed too.RESULTS:Fascin and CK14 were negative in the normal esophageal epithelia except in the basal cells. The positive rates of fascin and CK14 in the ESCC cells were 79.3% and 67.0% respectively. The positive rate of either fascin or CK14 was 86.2%. The expression rates of fascin and CK14 in well- and moderately-differentiated ESCCs were significantly higher than that in the poorly-differentiated ones (P = 0.054 and P < 0.01). The patients with positive expression of fascin and those with negative expression of CK14 had a poorer survival in comparison with those with negative fascin expression and those with positive CK14 expression respectively, however, without statistical significances (P = 0.8980 and P = 0.2610). The positive rates of fascin in the well-, moderately-, and poorly- differentiated ESCCs were 87.1%, 83.9%, and 62.1% respectively (P = 0.054). The positive rates of CK14 in the well-, moderately-, and poorly-differentiated ESCCs were; 87.1%, 76.4%, and 27.6% respectively (P < 0.01). The prognosis was not significantly correlated with the expression of both proteins (P = 0.8980 and P = 0.2610). There was an significantly positive correlation between the expression levels of these 2 proteins (r = 0.487, P < 0.01). Fascin was highly expressed in most of the ESCC lines, except in the slowly growing and weakly migrating TE12 line. High expression of CK14 was only seen in the line KYSE180.CONCLUSION:Fascin and CK14 may play important roles in the carcinogenesis and progression of ESCC. Combination of fascin and CK14 would be valuable markers in diagnosis of ESCC.

Cloning and identification of fascin gene promoter region in esophageal carcinoma cells

[Expression of Fascin and Cytokeratin 14 in Esophageal Squamous Cell Carcinoma].

Clone of human fatty acid synthase promoter and analysis of its transcriptional activity in tumor cells

[Expression of Fas, Fas Ligand, Fas-associated Death Domain Protein, Caspase 8 and Mutant P53 Protein in Esophageal Squamous Cell Carcinoma].

Comprehensive bioinformation analysis of the mRNA profile of fascin knockdown in esophageal squamous cell carcinoma.

Involvement of CYR61 and CTGF in the Fascin-Mediated Proliferation and Invasiveness of Esophageal Squamous Cell Carcinomas Cells.

Expression of Fascin in Esophageal Squamous Cell Carcinoma by Tissue Array Analysis

Fas Signaling Promotes Gastric Cancer Metastasis Through STAT3-Dependent Upregulation of Fascin.

Fascin1 Promotes Gastric Cancer Progression by Facilitatingcell Migrationand Epithelial-Mesenchymal Transition.

Cloning and Characterization of 5′UTR and Promoter Region of Chick Focal Adhesion Kinase Gene

Study on the Effect of Human CMV Early Transcriptional Enhancer on Human CEA Promoter

Cloning of survivin promoter and its specific transcriptional activities in gastric cancer cell line AGS

Fas/FasL Expression of Esophageal Squamous Cell Carcinoma, Dysplasia Tissues and Normal Mucosa

Cloning and Functional Analysis of the Promoter Region of an Intestinal Stem Cell Specific Expressed Gene,musashi-1

Cloning and functional analysis of the promoter of ZNF268 gene.

[Study of an Enhancer in Promoter Region of Human Colorectal Cancer Related ST13 Gene].

[The cloning of mouse FasL gene and expression in chondrocytes].

Fascin 1 Promoted the Growth and Migration of Non-Small Cell Lung Cancer Cells by Activating Yap/Tead Signaling

Promoter Methylation of RASSF1A Gene in Esophageal Tissue

Cloning and identification of survivin gene promoter segments with different activities

Characterization of VEGF Promoter Activity